As metabolic health continues to be a major focus, innovative treatments are appearing . Retatrutide, Tirzepatide, and Semaglutide represent a remarkable generation in GLP-1 receptor agonist medications. While https://toplistar.com/story24355174/retatrutid-vs-tirzepatid-vs-semaglutide-a-direct-analysis